Download Files:
(Rac)-EC5026
SKU
HY-135653A-10 mg
Category Reference compound
Tags Epoxide Hydrolase, Metabolic Enzyme/Protease, Neurological Disease
$300 – $2,250
Products Details
Product Description
– (Rac)-EC5026 ((Rac)-BPN-19186) is a potent piperidine inhibitor of soluble epoxide hydrolase (sEH) extracted from patent WO2019156991A1, page 39, has a Ki of 0.06 nM. (Rac)-EC5026 can be used for the research of Parkinson’s disease and dementia with Lewy Bodies (DLB)[1].
Web ID
– HY-135653A
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Neuroscience-Neurodegeneration
Molecular Formula
– C18H23F4N3O3
References
– [1]Hammock BD, et, al. Methods of inhibiting formation of alpha synuclein aggregates. WO2019156991A1.
CAS Number
– 1809885-55-9
Molecular Weight
– 405.39
Compound Purity
– 98.25
SMILES
– O=C(NC1CCN(C(C(C)CC)=O)CC1)NC2=CC=C(OC(F)(F)F)C(F)=C2
Clinical Information
– Phase 1
Research Area
– Neurological Disease
Solubility
– DMSO : 250 mg/mL (ultrasonic)
Target
– Epoxide Hydrolase
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.